Fenugreek Extract to Expand Market
date：2014-01-30
browse：（1072）
Keyword：
Stable market
With clinical data support, Fenugreek extract is mainly for treatment of diabetes. The ingredient is also preliminarily approved to tonify Yang in recent years.
The extract is primarily exported to North America, according to herbridge.com. The annual demand increases by 20 percent, but the combination of lower demand and higher technology requirements leads to fewer suppliers in China. The future market is expected to remain stable.
Patent awareness increases
With patent awareness increasing, manufacturers of Fenugreek extract work to get a patent. For example, Hunan Genham Biomeomoical Technology Ltd has got a patent for Furostanol saponins, and Chengdu Hosea Biotechnology Ltd has filed a patent application.
Copyright：Herbridge Media
Copyright：Herbridge Media
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
